MAD1L1 and colorectal carcinoma: Identified three methylation sites relevant to distinguishing CAC from sporadic CRC and defined methylation limit values. Combination of MICAL3, MAD1L1, and METTL22 methylation sites allowed for correct assignment to CAC or sporadic CRC in 94.5% of cases